(1)
Siregar, G.; Paramesh, R.; Kumawat, R.; D, P.; HA, S. A Prospective, Interventional Clinical Study to Evaluate the Safety and Efficacy of Liv.52 DS in the Management of Non-Alcoholic Fatty Liver Disease. Eur J Clin Exp Med 2021, 19, 129–136.